Rheumatic Disease Clinics of North America

Article	Citations
Pediatric Rheumatology Comes of Age: Part II	85
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	66
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	46
Copyright	33
Contents	33
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	27
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	24
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	22
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	22
Forthcoming Issues	21
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	20
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
COPA Syndrome from Diagnosis to Treatment	18
Copyright	18
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	16
Contributors	16
B Cells in Systemic Lupus Erythematosus	15
Imaging Challenges and Developments in Large-vessel Vasculitis	14
Taxonomy of Quality of Care Indicators	14
Lessons Learned from the COVID-19 Pandemic in Rheumatology	14
The Short and Long of COVID-19	14
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	14
Contents	13
Newer Immunosuppressants for Rheumatologic Disease	13

T Cells in Systemic Lupus Erythematosus	13
It Takes Oysters to Generate Pearls	12
Vaccinations in Patients with Rheumatic Disease	12
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11
De novo Connective Tissue Disorders as Immune-related Adverse Events	11
Contents	11
Copyright	10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	10
Expanding the Treatment Team	10
Uveitis in Children and Adolescents	9
Primary Cardiac Involvement in Systemic Sclerosis	9
Pulmonary Hypertension Associated with Connective Tissue Disease	9
Rheumatology Pearls for the Primary Care Physician	8
Scleroderma: Best Approaches to Patient Care	8
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	7
COVID-19 and Rheumatology	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Cardiac MRI in Rheumatic Disease	7
Contributors	6
Charles L Christian	6
Heart Failure in Rheumatic Disease	6
Contents	6
Preventative Care in Scleroderma	6
Systemic Lupus Erythematosus Classification and Diagnosis	6
Contributors	6
A Guide to Contemporary Clinical Practice Guidelines	6
Chronic Nonbacterial Osteomyelitis	6
Guideline Development and Implementation in Rheumatic Disease	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
Imaging of the Major Salivary Glands in Rheumatic Disease	5
Copyright	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Copyright	5
E Carwile LeRoy, MD	5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	5
Forthcoming Issues	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	5
Contributors	5
The Power of Systems Biology	5
Beyond Coronary Artery Disease	5
CARRA	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
The Role of Psychology in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4

Dual-Energy Computed Tomography Applications in Rheumatology	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Patient Engagement in Pediatric Rheumatology Research	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Management and Cure of Gouty Arthritis	4
Treatment Guidelines in Gout	4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Role of Environment in Pediatric Rheumatic Diseases	4
Copyright	4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	3
Health Care Utilization	3
Forthcoming Issues	3
Interferons in Systemic Lupus Erythematosus	3
Contents	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	3
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	3
Pediatric Rheumatology Comes of Age: Part I	3
Imaging in Inflammatory Bowel Disease	3
Interstitial Lung Disease	3
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	2
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials	2
Perioperative Management of Rheumatic Disease and Therapies	2
Systemic Diseases and Heart Block	2
Preface	2
Contributors	2
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases	2
COVID-19 in Pediatrics	2
Technology to Assess and Treat Pain in Pediatric Rheumatology	2
The GRADE Method	2
Imaging in Juvenile Idiopathic Arthritis	2
Forthcoming Issues	2
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	2
Outcome Measures in Pediatric Rheumatic Disease	2
Precision Medicine	2
Forthcoming Issues	2
Training the Next Generation of Rheumatologists	2
Pediatric Rheumatology Comes of Age: Part II	2
Mental Health in Pediatric Rheumatology	2
Contributors	2
Nathan Zvaifler	2
J. Claude Bennett, MD	2
Targeting Environmental Risks to Prevent Rheumatic Disease	2
Forthcoming Issues	2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	2
The Giants Of Rheumatology	1
Contributors	1
The Promises and Perils of Social Media for Pediatric Rheumatology	1
Vasculitis	1
Treatment Guidelines in Vasculitis	1
Long COVID for the Rheumatologist	1
Treatment of Inflammatory Arthritis in Systemic Sclerosis	1
Treatment Update in Systemic Lupus Erythematous	1
Recent Updates in Juvenile Spondyloarthritis	1
Imaging in Rheumatology	1
Gerald P Rodnan	1
Foreword	1
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis	1
Transitioning to Adulthood with a Rheumatic Disease	1
Highlights of Interdisciplinary Care in Rheumatology	1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	1
Cardiovascular Disease in Large Vessel Vasculitis	1
Contributors	1
Forthcoming Issues	1
Forthcoming Issues	1
Juvenile Fibromyalgia	1
Pediatric Rheumatology Comes of Age: Part I	1
Treatment of Vascular Complications in Systemic Sclerosis	1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	1
Targeted Treatment of Diseases of Immune Dysregulation	1
The Current and Future of Biomarkers of Immune Related Adverse Events	1
Axial Imaging in Spondyloarthritis	1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	1
Cardiovascular Complications of Chronic Rheumatic Diseases	0
Eric Bywaters and Barbara Ansell	0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases	0
Forthcoming Issues	0

Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy	0
Contents	0
Imaging Revolutions in Modern Rheumatology	0
Scleroderma Skin	0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis	0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases	0
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	0
Disparities in Pediatric Rheumatic Diseases	0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis	0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	0
Vasculitis and Pregnancy	0
Forthcoming Issues	0
Preventative Care in Scleroderma	0
Central Nervous System Imaging in Rheumatic Diseases	0
New Developments in Imaging in Crystalline Arthritis	0
Contributors	0
Forthcoming Issues	0
The Emerging Telehealth Landscape in Pediatric Rheumatology	0
Juvenile Localized Scleroderma	0
New and Emerging Rheumatic Diseases	0
Lessons on Telemedicine in Rheumatology	0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
Managing Cardiovascular Risk in Patients with Rheumatic Disease	0
Environmental Risks for Spondyloarthropathies	0
Innovative Trials and New Opportunities in SLE	0
Lupus Cohorts	0
Management of Pregnancy in Lupus	0
Gastrointestinal Tract Considerations: Part II	0
Foreword	0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases	0
Forthcoming Issues	0
Copyright	0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients	0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression	0
Coronavirus Disease-2019 in the Immunocompromised Host	0
Environmental Risks for Systemic Sclerosis	0
Emerging Concepts in Immune Dysregulation	0
Giant Cell Arteritis and Polymyalgia Rheumatica	0
Contributors	0
Patient Experience of Systemic Sclerosis–Related Calcinosis	0
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	0
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases	0
Type I Interferonopathies	0
Environmental Triggers for Rheumatic Diseases	0
Vasculitis Mimics and Other Related Conditions	0
Immune Checkpoint Inhibitor-induced Sicca Syndrome	0
Forthcoming Issues	0
Contents	0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease	0
Environmental Risks for Inflammatory Myopathies	0
Contents	0
Naomi Rothfield, MD, MACR	0
Emerging Concepts in Immune Dysregulation	0
Lupus	0
Copyright	0
The Future of Vasculitis	0
Rheumatic Immune-related Adverse Events	0
Contents	0
How the American College of Rheumatology Develops Guidelines	0
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	0
Isolated Aortitis	0
Guideline Development and Implementation in Rheumatic Disease	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
Rheumatology Pearls for the Primary Care Physician	0
Vasculitis	0
Forthcoming Issues	0
Lessons from Carl M. Pearson 1919 – 1981	0
Rheumatoid Arthritis	0
Statin-Associated Myalgias and Muscle Injury—Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein	0
Environmental Triggers for Rheumatic Diseases	0
Forthcoming Issues	0
Immunotherapy Toxicity Management in Clinical Practice	0
Copyright	0
Edmund Lawrence Dubois (1923–1985)	0
Contributors	0
Environmental Triggers for Vasculitis	0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination	0
Highlights of Interdisciplinary Care in Rheumatology	0
Pediatric Rheumatology Comes of Age: Part I	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Gut and Joint Microbiomes	0
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus	0
Systemic Autoinflammatory Diseases	0
Mental Health Considerations in Chronic Disease	0
Contents	0
Copyright	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Scleroderma: Best Approaches to Patient Care	0
Pediatric Rheumatology Comes of Age: Part II	0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	0
Systemic Lupus Erythematosus Risk	0
Suppressor of Cytokine Signaling 1 Haploinsufficiency	0
Central Nervous System Vasculitis	0
Newer Immunosuppressants for Rheumatologic Disease	0